Author Correction: Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial
Jerilynn C. Prior, Andrea Cameron, Michelle Fung, Christine L. Hitchcock, Patricia Janssen, Terry Lee, Joel Singer
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsUrticaria and Related Conditions · Sympathectomy and Hyperhidrosis Treatments · Estrogen and related hormone effects
Correction to: Scientific Reports 10.1038/s41598-023-35826-w, published online 05 June 2023
The original version of this Article contained errors in Table 2, where the values in the “All”, “Progesterone” and “Control” columns were incorrect for the Perimenopause Interference Questionnaire and Personal Health Questionnaire 9 (PHQ-9).
The correct and incorrect values appear below.
Incorrect:VariablesAll (n = 189)Progesterone (n = 93)Control (n = 96)RR (95% CI)*RD (95% CI)**PPerimenopause Interference Questionnaire5.1 (4.4)4.8 (4.4)5.4 (4.3)− 6.65 (− 12.11, − 1.18)^^^0.017Personal Health Questionnaire 9 (PHQ-9)25.3 (20.2)22.6 (18.3)28.2 (21.7)− 0.40 (− 1.57, 0.77)^^^0.501
Correct:VariablesAll (n = 189)Progesterone (n = 93)Control (n = 96)RR (95% CI)*RD (95% CI)**PPerimenopause Interference Questionnaire25.3 (20.2)22.6 (18.3)28.2 (21.7)− 6.65 (− 12.11, − 1.18)^^^0.017Personal Health Questionnaire 9 (PHQ-9)5.1 (4.4)4.8 (4.4)5.4 (4.3)− 0.40 (− 1.57, 0.77)^0.501
The original Article has been corrected.